OrganOx Revenue and Competitors
Estimated Revenue & Valuation
- OrganOx's estimated annual revenue is currently $30.1M per year.
- OrganOx's estimated revenue per employee is $251,000
Employee Data
- OrganOx has 120 Employees.
- OrganOx grew their employee count by 94% last year.
OrganOx's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | SVP North America Operations | Reveal Email/Phone |
3 | VP Clinical Engagement | Reveal Email/Phone |
4 | Quality Officer | Reveal Email/Phone |
5 | Global Director Quality and Regulatory Affairs | Reveal Email/Phone |
6 | Director Clinical Support, North America | Reveal Email/Phone |
7 | Director, Training & Education | Reveal Email/Phone |
8 | Director Sales, North America | Reveal Email/Phone |
9 | Marketing Director | Reveal Email/Phone |
10 | Global Commercial Director | Reveal Email/Phone |
OrganOx Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is OrganOx?
"Living Organs For Life" Transforming transplantation with the OrganOx metra®. A transportable, automated ex vivo liver perfusion device. The core technology employed by the OrganOx metra® has been in development for over 15 years. During this time both of the founders (Professor Peter Friend and Professor Constantin Coussios) have driven the development of organ preservation and maintenance, formerly at the University of Cambridge and latterly at the University of Oxford. OrganOx Limited was founded in April 2008 as a spin-out from the University of Oxford. Conventional cold preservation involves storage of the liver at 4˚C, using a non-physiological perfusion solution that aims to minimise liver decay. By contrast, warm preservation seeks to re-create an environment that mimics the human body by continuously perfusing at physiological pressures and flows with oxygen-carrying red cells at 37˚C and providing nutrition. The liver is therefore functional during the preservation period, producing bile, metabolizing glucose and maintaining a physiological pH. This enables objective assessment of organ performance prior to transplant, extended preservation times, and the potential use of organs that are presently being discarded.
keywords:N/AN/A
Total Funding
120
Number of Employees
$30.1M
Revenue (est)
94%
Employee Growth %
N/A
Valuation
N/A
Accelerator
OrganOx News
... Dr. Franz K hler Chemie GmbH, XVIVO Perfusion AB, Organox Limited, Shanghai Genext Medical Technology, Waters Medical Systems.
LifeShare Oklahoma partners with OrganOx and Ochre Bio to study perfusion technology that sustains livers outside a donor's body.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $18M | 124 | 72% | N/A |
#2 | $26M | 124 | -6% | N/A |
#3 | $18.1M | 125 | 20% | N/A |
#4 | $15M | 125 | 15% | N/A |
#5 | $34M | 126 | 24% | N/A |